Intraoperative Resection Guidance and Rapid Pathological Diagnosis of Osteosarcoma using B7H3 Targeted Probe under NIR‐II Fluorescence Imaging
Top Cited Papers
Open Access
- 19 March 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (33) , e2310167
Abstract
Complete removal of all tumor tissue with a wide surgical margin is essential for the treatment of osteosarcoma (OS). However, it's difficult, sometimes impossible, to achieve due to the invisible small satellite lesions and blurry tumor boundaries. Besides, intraoperative frozen‐section analysis of resection margins of OS is often restricted by the hard tissues around OS, which makes it impossible to know whether a negative margin is achieved. Any unresected small tumor residuals will lead to local recurrence and worse prognosis. Herein, based on the high expression of B7H3 in OS, a targeted probe B7H3‐IRDye800CW is synthesized by conjugating anti‐B7H3 antibody and IRDye800CW. B7H3‐IRDye800CW can accurately label OS areas after intravenous administration, thereby helping surgeons identify and resect residual OS lesions (<2 mm) and lung metastatic lesions. The tumor‐background ratio reaches 4.42 ± 1.77 at day 3. After incubating fresh human OS specimen with B7H3‐IRDye800CW, it can specifically label the OS area and even the microinvasion area (confirmed by hematoxylin‐eosin [HE] staining). The probe labeled area is consistent with the tumor area shown by magnetic resonance imaging and complete HE staining of the specimen. In summary, B7H3‐IRDye800CW has translational potential in intraoperative resection guidance and rapid pathological diagnosis of OS.Keywords
Funding Information
- National Natural Science Foundation of China (82373140, 81972509, 62027901)
- Natural Science Foundation of Beijing Municipality (7232193)
- Fundamental Research Funds for the Central Universities (JKF‐YG‐22‐B005)
This publication has 53 references indexed in Scilit:
- A Gas/phototheranostic Nanocomposite Integrates NIR‐II‐Peak Absorbing Aza‐BODIPY with Thermal‐Sensitive Nitric Oxide Donor for Atraumatic Osteosarcoma TherapyAdvanced Materials, 2023
- Rational Design of a Self‐Assembling High Performance Organic Nanofluorophore for Intraoperative NIR‐II Image‐Guided Tumor Resection of Oral CancerAdvanced Science, 2023
- New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissueEuropean Journal of Nuclear Medicine and Molecular Imaging, 2022
- Osteosarcoma: A Surveillance, Epidemiology, and End Results program‐based analysis from 1975 to 2017Cancer, 2022
- Multifunctional Dynamic Enamine‐Based Hydrogels with On‐Demand Removability for Wound HealingAdvanced Materials Interfaces, 2021
- Standardized intraoperative 5-ALA photodynamic therapy for newly diagnosed glioblastoma patients: a preliminary analysis of the INDYGO clinical trialJournal of Neuro-Oncology, 2021
- Surgical Navigation for Malignancies Guided by Near‐Infrared‐II Fluorescence ImagingSmall Methods, 2021
- Children's Oncology Group's 2013 blueprint for research: Bone tumorsPediatric Blood & Cancer, 2012
- Targeted non-covalent self-assembled nanoparticles based on human serum albuminBiomaterials, 2012
- B7‐H3 contributes to the metastatic capacity of melanoma cells by modulation of known metastasis‐associated genesInternational Journal of Cancer, 2011